Skip to content
  • After meningitis outbreak, insurers are reportedly reluctant to cover compounded medications

    WGBH - 06/26/2017

    “Insurance companies have really clamped down on the coverage of compounded medications,” said Todd Brown, a pharmacy professor at Northeastern University and executive director of the Massachusetts Independent Pharmacists Association.

    Brown says the reduction in coverage came after the meningitis outbreak at the New England Compounding Center.

    Brown says insurers saw the headlines and they saw other compounding pharmacies taking advantage of lax rules, so they tightened compounding coverage across the board.

  • Cookies on Northeastern sites

    This website uses cookies and similar technologies to understand your use of our website and give you a better experience. By continuing to use the site or closing this banner without changing your cookie settings, you agree to our use of cookies and other technologies. To find out more about our use of cookies and how to change your settings, please go to our Privacy Statement.